Verender Badial
Directeur Financier/CFO chez ZURA BIO LIMITED
Fortune : 4 M $ au 31/05/2024
Provenance du réseau au premier degré de Verender Badial
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Verender Badial via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Corporate Officer/Principal Director/Board Member | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
D.E. Shaw & Co., Inc.
 D.E. Shaw & Co., Inc. Investment ManagersFinance D.E. Shaw & Co., Inc. engages in the provision of investment advisory services. The firm offers services to pooled investment vehicles. The company was founded by David E. Shaw in 1988 and was headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal Human Resources Officer Compliance Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Graduate Degree | |
| University of Adelaide | College/University | Doctorate Degree | |
| University of Oxford | College/University | Graduate Degree | |
| University of London | College/University | Graduate Degree | |
| University of Messiah | College/University | Undergraduate Degree | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| University of California, Riverside | College/University | Undergraduate Degree | |
| University of Groningen | College/University | Graduate Degree | |
| Université Libre de Bruxelles | College/University | Doctorate Degree | |
SMART Reading /Oregon/
 SMART Reading /Oregon/ Miscellaneous Commercial ServicesCommercial Services SMART Reading offers literacy support to children. It helps kids become confident readers by providing individual volunteer attention and new, take-home books. The company was founded in 1992 and is headquartered in Portland, OR. | Miscellaneous Commercial Services | Director/Board Member | |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Chief Executive Officer | |
| Graduate School of Business | College/University | Masters Business Admin | |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| West Virginia University School of Medicine | College/University | Doctorate Degree | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Chief Tech/Sci/R&D Officer | |
| Oxford University Medical School | College/University | Undergraduate Degree | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Athanor Capital LP
 Athanor Capital LP Investment ManagersFinance Athanor Capital LP (Athanor) is a hedge fund manager headquartered in New York City. The firm was founded by Parvinder S. Thiara in 2017 and is a subsidiary of Athanor Capital GP LLC. Athanor serves as the investment adviser, with discretionary trading authority over private pooled investment vehicles. | Investment Managers | Founder | |
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017. | Biotechnology | Chief Executive Officer | |
| DERMTECH, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Founder | |
| JATT Ventures LP | Chief Executive Officer | ||
| Allianthera Suzhou Biopharmaceutical Co Ltd | Founder | ||
| Akaza Bioscience Ltd. | Chief Executive Officer | ||
| Zenios Bioscience LLP | Chief Executive Officer | ||
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Founder | |
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| CADRENAL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| METACRINE, INC. | Biotechnology | Chief Executive Officer Human Resources Officer |
Statistiques
Internationale
| Etats-Unis | 28 |
| Royaume-Uni | 10 |
| Îles Cayman | 3 |
| Allemagne | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 4 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 58 |
| Corporate Officer/Principal | 40 |
| Independent Dir/Board Member | 23 |
| Chief Executive Officer | 21 |
| Chief Tech/Sci/R&D Officer | 19 |
Relations les plus connectées
| Insiders | |
|---|---|
| Amit Munshi | 27 |
| Jennifer Jarrett | 18 |
| Christopher Cabell | 16 |
| Preston Klassen | 15 |
| Neil Graham | 14 |
| Sandeep Kulkarni | 11 |
| Steven Schoch | 11 |
| Michael Howell | 10 |
| Robert Lisicki | 9 |
| Theresa Lowry | 9 |
| Someit Sidhu | 8 |
| Parvinder Singh Thiara | 7 |
| Kimberly Ann Davis | 7 |
| Javier Cote-Sierra | 6 |
| Gary Whale | 5 |
- Bourse
- Insiders
- Verender Badial
- Connexions Sociétés
